Results 71 to 80 of about 12,403 (234)

Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: real-world database analysis.

Modern Rheumatology, 2023
OBJECTIVES Report the prevalence of eosinophilic granulomatosis with polyangiitis (EGPA) and describe oral corticosteroid (OCS) use and disease burden before and after mepolizumab approval in 2018 for EGPA in Japan.
K. Sada, Takeo Suzuki, S. Joksaite, Shinyoung Ju, John Logie, George Mu, J. Hwee, H. Kunishige, Takeo Ishii, A. Adlak, H. Vadlamudi, R. Alfonso-Cristancho   +11 more
semanticscholar   +1 more source

Head and Neck Manifestations of Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review. [PDF]

, 2016
OBJECTIVE: To conduct the first and only systematic review of the existing literature on head and neck manifestations of eosinophilic granulomatosis with polyangiitis to guide clinical decision making for the otolaryngologist.
Basnyat, Shristi, Goldfarb, Jared M., Nyquist, Gurston G., Rabinowitz, Mindy R., Rosen, Marc R.   +4 more
core   +1 more source

Fulminant Eosinophilic Myocarditis

JACC: Case Reports, 2020
We describe a case of fulminant eosinophilic myocarditis as the first presentation of eosinophilic granulomatosis with polyangiitis, promptly managed with extracorporeal membrane oxygenation.
Pedro M. Lopes, MD, Bruno M.L. Rocha, MD, Gonçalo J.L. Cunha, MD, Sara Ranchordas, MD, Catarina Albuquerque, MD, António M. Ferreira, MD, Carlos Aguiar, MD, Marisa Trabulo, MD, José P. Neves, MD, Miguel Mendes, MD   +9 more
doaj   +1 more source

Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis

Respiratory Medicine Case Reports, 2022
Eosinophils play an important pathogenetic role in the development of eosinophilic granulomatosis with polyangiitis (EGPA). EGPA has long been treated with systemic corticosteroids and immunosuppressive agents.
Osamu Matsuno, Seijiro Minamoto
doaj   +1 more source

Dupilumab-Associated Eosinophilic Granulomatosis With Polyangiitis

Cureus, 2022
A 58-year-old Caucasian male developed generalized weakness, bilateral upper and lower extremity arthralgias, left pedal edema, and a new rash over two weeks after receiving one dose of dupilumab for chronic sinusitis. He was found to be positive for perinuclear anti-neutrophil cytoplasmic antibodies and myeloperoxidase, with evidence of interstitial ...
Persaud, Purnadeo, Karmali, Rehan, Sankar, Parvathy, Majid, Muhammad   +3 more
openaire   +2 more sources

Refractory diffuse alveolar hemorrhage caused by eosinophilic granulomatosis with polyangiitis in the absence of elevated biomarkers treated successfully by rituximab and mepolizumab: A case report

Respiratory Medicine Case Reports, 2019
Here we report on a 61-year-old man with refractory eosinophilic granulomatosis with polyangiitis (EGPA) who presented with dyspnea. Despite treatment with glucocorticoids, intravenous cyclophosphamide, and plasma exchange, his symptoms worsened despite ...
Akihiro Shiroshita, Kei Nakashima, Shinji Motojima, Masahiro Aoshima   +3 more
doaj   +1 more source

Positivity to p-ANCA in patients with status epilepticus [PDF]

, 2014
BACKGROUND: Status epilepticus (SE) may occur in the setting of several internal or neurologic diseases. Anti-neutrophilic cytoplasmic antibodies (ANCA) are a group of Ig that may be observed in patients with different autoimmune disorders but are ...
Angelo Labate, Antonio Gambardella, Concetta Russo, Edoardo Ferlazzo, Laura Mumoli, Marina Bellavia, Sara Gasparini, Umberto Aguglia, Vittoria Cianci   +8 more
core   +1 more source

The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review

Rheumatology International, 2023
Eosinophilic granulomatosis with polyangiitis (EGPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, mostly affecting small-sized arteries and usually occurring in patients with an allergic background.
Ioannis Kouverianos, A. Angelopoulos, D. Daoussis   +2 more
semanticscholar   +1 more source

Use of Plasmapheresis and Immunosuppressants to Treat Diffuse Alveolar Hemorrhage in a Patient with Granulomatosis with Polyangiitis. [PDF]

, 2019
Granulomatosis with polyangiitis (GPA) is a systemic granulomatous inflammatory disease characterized by small-to-medium vessel vasculitis due to Central Anti-Neutrophil Cytoplasmic Antibody (C-ANCA).
Sattar, Yasar, Susheela, Ammu Thampi, Ullah, Waqas, Usman, Norina, Zafrullah, Fnu   +4 more
core   +1 more source

ANCA-positive vasculitis: Clinical implications of ANCA types and titers [PDF]

, 2016
INTRODUCTION: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disease that can affect multiple organs, the kidney being one of the most affected.
Domingues, V., Machado, B., Santos, J.
core   +1 more source